Pros | Beats FD returns for both 3Y & 5Y duration. | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | - | - |
INDMoney rank | 3/8 | 6/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 3 Months | 13 Years 3 Months | ||
Fund AUM | ₹1311 Cr | ₹8265 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.62% | 0.92% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 38 | 39 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 1 | ||
Top 3 Sectors |
| Health (100%) | ||
Equity % | 98.69% | 97.37% | ||
Debt % | - | - | ||
P/E | 42.03 | 35.17 | ||
P/B | 6.88 | 5.57 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -4.7% | -2.84% | ||
3-Month Return | -6.29% | -3.72% | ||
6-Month Return | -4.33% | -2.78% | ||
1-Year Return | -1.97% | 1.67% | ||
3-Year Return | 23.41% | 23.25% | ||
5-Year Return | 15.44% | 15.04% |
Sharpe | 0.93 | 0.97 | ||
Alpha | 1.41 | 0.33 | ||
Beta | 0.94 | 0.9 | ||
Standard Deviation | 16.37 | 15.32 | ||
Information Ratio | 0.21 | -0.32 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sailesh Raj Bhan, Divya Sharma, Kinjal Desai, Lokesh Maru |